Clinical Trial Update: A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial (PATENCY-1) evaluating PRT-201 administered after AVF creation in chronic kidney disease patients; study completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• PRT-201

Snippet

Sponsor: Proteon Therapeutics | Conditions: Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2019-07-09